This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Vladimir Hachinski, MD, FRCPC, DSc (Med)
University Hospital PO Box 5339 London, Ontario, Canada N6A 5A5

Arch Neurol. 1989;46(9):948.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Nothing improves therapeutic results more than the omission of controls. Pritchard's systematic approach and extensive experience are impressive, but is it because of or despite magnesium sulfate? He provides nothing for comparison.

I agree that one does not need to understand the pathophysiology of eclampsia in order to treat it; however, one needs more than cumulative uncontrolled results in order to claim effectiveness for a drug.

Pritchard's quotation of preliminary work on the use of magnesium sulfate in cerebral ischemia and seizures buttresses my conclusion that magnesium sulfate belongs in the laboratory, a clinical trial, or history. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?